Back to News
Market Impact: 0.5

Guru Fundamental Report for LRCX

LRCXNDAQ
Company FundamentalsCorporate EarningsCapital Returns (Dividends / Buybacks)Technology & InnovationAnalyst InsightsInvestor Sentiment & Positioning
Guru Fundamental Report for LRCX

Validea's guru fundamental report highlights Lam Research Corporation (LRCX), a large-cap semiconductor growth stock, as scoring 86% on its 'Patient Investor' model, which is based on Warren Buffett's strategy. This strong rating indicates LRCX's significant alignment with criteria for long-term, predictable profitability and low debt, positioning it as a noteworthy candidate for investors seeking fundamentally sound companies with reasonable valuations, even within the growth-oriented semiconductor sector.

Analysis

Lam Research Corporation (LRCX) exhibits a strong fundamental profile according to Validea's 'Patient Investor' model, which is based on Warren Buffett's investment principles. The company, a large-cap growth stock in the semiconductor industry, achieved a score of 86%, indicating a high degree of alignment with criteria focused on long-term predictable profitability, low debt, and reasonable valuation. The analysis reveals that LRCX passes critical tests for Earnings Predictability, Debt Service, Free Cash Flow, and Share Repurchase, suggesting robust financial health and a shareholder-friendly capital allocation strategy. However, the model also flagged a specific weakness, as the company failed to meet the 'Return on Total Capital' criterion. Despite this single point of failure, the overwhelmingly positive results on other metrics, including Return on Equity and Expected Return, position LRCX as a fundamentally sound company that, according to this specific quantitative screen, is attractively valued.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo